TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/17/24 16:48 | 7/15/24 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lew Jennifer | CA | O | EVP,CFO | S | -7 | 6.03 | 0 | -1 | -1 | 86 | D | ||||||||||||||
2/21/24 16:31 | 2/20/24 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lew Jennifer | CA | O | EVP,CFO | S.d | -14 | 5.53 | 0 | -3 | -3 | 82 | D | ||||||||||||||
2/14/24 19:54 | 2/12/24 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lew Jennifer | CA | O | EVP,CFO | S | -10 | 5.54 | 0 | -2 | -4 | 46 | D | ||||||||||||||
1/23/24 16:57 | 7/11/23 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lew Jennifer | CA | O | EVP,CFO | S | -4 | 3.84 | 0 | -1 | -2 | 47 | D | ||||||||||||||
2/15/23 18:59 | 2/13/23 | ANNX | Annexon, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lew Jennifer | CA | O | EVP,CFO | S.m | -12 | 6.31 | 0 | -2 | -6 | 30 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |